Axio Biosolutions Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:N/A
Industry:Medical Equip
Lead Investor(s):N/A

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Axio Biosolutions's estimated annual revenue is currently $34.6M per year.(?)
  • Axio Biosolutions's estimated revenue per employee is $251,000

Employee Data

  • Axio Biosolutions has 138 Employees.(?)
  • Axio Biosolutions grew their employee count by 6% last year.
  • Axio Biosolutions currently has 1 job openings.

Axio is a deep science medtech company focused on Advanced Surgical, Trauma and woundcare. Makers of India's first USFDA cleared hemostat - AXIOSTAT (a patented, Fda 510k and CE approved medical device made from 100% Chitosan) and MaxioCel (a chitosan microfiber dressing for Diabetic foot ulcers and other chronic ulcers) Axio develops and commercializes active medical products using novel biomaterials for advanced woundcare. We believe in creating value by delivering affordable solutions for unmet health care needs.

keywords:Healthcare, Medical Devices, Defense, Hospitals